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Deletion of the heme oxygenase-1 (HO-1) (Hmox1) locus in mice results in intrauterine
lethality. The expression of the heme catabolizing enzyme encoded by this gene, namely
HO-1, is required to successfully support reproductive events.We have previously observed
that HO-1 acts at several key events in reproduction ensuring pregnancy. HO-1 defines ovu-
lation, positively influences implantation and placentation, and ensures fetal growth and
survival. Here, we embarked on a study aimed to determine whether hormonal changes
during the estrous cycle in the mouse define HO-1 expression that may influence recep-
tivity. We analyzed the serum levels of progesterone and estrogen by ELISA and HO-1
mRNA expression in uterus by real time RT-PCR at the metestrus, proestrus, estrus, and
diestrus phases of the estrous cycle. Further, we studied the HO-1 protein expression by
western blot upon hormone addition to cultured uterine AN3 cells. We observed that HO-1
variations in uterine tissue correlated to changes in hormonal levels at different phases of
the estrus cycle. In vitro, HO-1 protein levels in AN3 cells augmented after the addition
of physiological concentrations of progesterone and estradiol, which confirmed our in vivo
observations. Our data suggest an important role for hormones in HO-1 regulation in uterus
during receptivity, a process known to have a significant impact in receptivity and later on
blastocyst implantation.
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INTRODUCTION
Heme oxygenases (HOs) catalyze heme catabolism toward
biliverdin, carbon monoxide (CO), and free iron (1). The stress-
responsive heme oxygenase-1 (HO-1) isoform, encoded by the
Hmox1 gene, is cytoprotective and modulates anti-inflammation
[(2); reviewed in Ref. (3, 4)] as well as cell proliferation prevent-
ing tissue injury and regulating innate as well as adaptive immune
responses (5).
During normal pregnancy, complex processes take place in a
defined succession, each of them being unique. Pregnancy begins
with the fertilization of the ovum, followed by implantation of
the blastocyst in the maternal uterus. To implant, the blastocyst
needs to adhere to the endometrium and be provided with oxygen
and nutrients. For these dramatic changes to occur, uterine tissue
remodeling and inflammatory processes are required. As the abla-
tion of immunosuppressive molecules is detrimental, it has to be
assumed that both inflammatory and anti-inflammatory pathways
are required (6, 7). HO-1 seems to be a crucial player interfering
with many – if not all – of these sequenced processes. We have
recently showed that HO-1 defines ovulation (8) and is critical for
pregnancy success, regulating proper implantation, placentation,
and intrauterine fetal survival (7). After implantation occurred
and while placentation is taking place, a period of immune toler-
ance must exist that allows the half-foreign fetus to grow without
being attacked by the maternal immune system. Also at this step,
HO-1 is of importance. It modulates the maternal immune sys-
tem to allow tolerance toward the growing fetus by affecting the
function of dendritic cells and regulatory T cells (9, 10). Hence,
HO-1 is a central regulator of pregnancy as it critically interferes
with important steps namely ovulation, implantation, placenta-
tion, fetal development, and immune tolerance. Poor reproductive
outcome of Hmox1-deficient animals may however be additionally
due to defects in receptivity upon hormonal changes.
As nidation and later implantation much depends on the uter-
ine receptivity (11) and we observed that both processes are
defective in the absence of HO-1 (7), we hypothesized that normal
hormonal changes during the estrous cycle would modulate HO-1
expression. At receptivity, the uterine tissue undergoes dramatic
changes, all of them preparing the uterus for a possible nidation of
the fertilized egg. HO-1 might be implied in tissue protection dur-
ing receptivity because of its known roles as anti-inflammatory,
tissue-protective, and anti-oxidant enzyme (12). Here, we show
that hormonal changes as observed at the different phases of the
estrous cycle provoke important variations on the levels of HO-
1 in vivo. HO-1 peaks at receptivity and significantly correlates
with the progesterone peak. In vitro, combined estrogen and prog-
esterone application leads to increased HO-1 protein expression
in uterine cells. Thus, hormonal changes during the estrous cycle
dictate HO-1 uterine levels. Our data contributes to the under-
standing of how hormones condition the uterine environment to
be prepared for nidation of the fertilized egg.
MATERIALS AND METHODS
DETERMINATION OF THE PHASES OF THE ESTROUS CYCLE
For testing the different phases of the estrous cycle in Hmox1+/+
animals, vaginal smears were obtained daily and stained as
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explained elsewhere (13). HO-1 mRNA levels were measured in
uterus and spleen normalized to beta-actin by using TaqMan
technology as described below.
HORMONE MEASUREMENTS
Levels of progesterone and estradiol were analyzed in plasma sam-
ples from wild type females at different stages of their estrous
cycle (BALB/c Hmox1+/+ mice). Progesterone was measured by
LIA (chemiluminescence immunoassay) using a kit from Diag-
nostics Biochem Canada Inc., ON, Canada. RLUs were measured
in microplate luminometer (Micromat Plus LB 96V) at 0.1 and 2 s
and the values were expressed as RLU/s. Estradiol levels were mea-
sured by ELISA using a kit from Diagnostics Biochem Canada
Inc., using a microplate well reader at 450 nm following the
manufacturer’s instructions.
HEME MEASUREMENT
Heme was measured in uterine lavage. Briefly, uteri of the females
were flushed with 150 ml of saline solution. Plasma and lavage
were both passed through a Microcon YM-3 column (Millipore;
90 min at 14°C, 16,000× g ) to remove proteins (MW> 3 kDa).
We quantified free heme in protein-depleted uterine lavage using
a chromogenic assay according to the manufacturer’s instructions
(QuantiChrom heme assay kit, Bioassay Systems).
RNA ISOLATION AND cDNA SYNTHESIS
RNA extraction was performed using Trizol reagent. Briefly, tissues
(spleen, uterus, liver) were homogenized in Trizol using an Ultra-
Turrax T25 homogenizer. After adding chloroform and vortexing
for 2 min at RT, samples were centrifuged at 10,000× g for 10 min
at 4°C. The upper phase obtained after the centrifugation was then
transferred to a new tube, and ice-cold ethanol was added. After
an incubation of 10 min at −20°C, samples were centrifuged for
10 min at 10,000× g at 4°C. The pellet obtained after this centrifu-
gation was then washed three times with ethanol 80° and between
each wash step, cells were centrifuged for 10 min at 10,000× g at
4°C. After the last wash, the pellet was allowed to dry and it was re-
suspended with RNase-free water. RNA concentration was deter-
mined by measuring OD at 260 nm. For cDNA synthesis, samples
containing 2µg of total RNA were placed for 2 min on ice and
added with dNTPs [(2.5 mM), Amersham Pharmacia, Munich,
Germany], DNase I (2 U/µl, Stratagene, Waldbronn, Germany),
and RNase-inhibitor (40 U/µl) mixed in reaction buffer. The mix
was incubated for 30 min at 37°C and further heated to 75°C for
5 min. The addition of the reverse transcriptase (200 U/µl) and
RNase-inhibitor in distilled water started the reverse transcription.
This reaction mixture was incubated at 42°C for 60 min followed
by incubation at 94°C for 5 min. Once the cDNA synthesis was
completed, the samples were immediately used or kept at−20°C.
REAL TIME PCR
For HO-1 amplification, TaqMan technology was employed as
described elsewhere (14). One microliter of cDNA was used as
starting volume to amplify the DNA. PCR-Mastermix (6.25µl;
Eurogentec, Cologne, Germany), 3µl of the primer mix, 0.5µl
of the fluorescent probes, and RNase-free water were added to a
final volume of 13µl. The amplification reactions were performed
on the ABI Prism 7700 sequence detection system (PerkinElmer
Applied Biosystems, Darmstadt, Germany) as follows: 2 min at
50°C, followed by an initial denaturation step of 10 min at 95°C,
and 40 cycles of 15 s at 95°C and 1 min at 60°C. β-actin was used
as housekeeping gene.
CULTURE OF UTERINE CELLS AND TREATMENT WITH HORMONES
The human uterine cell line (AN3), which is representative of
the non-receptive phase of the uterine tissue (15, 16), was pur-
chased from the American Type Culture Collection (ATCC, Wesel,
Germany). Cells were maintained in MEM medium (Life Tech-
nology, Darmstadt, Germany) supplemented with FBS (10%,
Biochrom, Berlin, Germany), 1% of non-essential amino acids
(NEAA), 1 mM sodium pyruvate, and antibiotics (Life Technol-
ogy, Darmstadt, Germany). For hormonal treatment experiments,
5× 105 cells were cultured for 24 h on a 24 well-plate with 1 ml of
MEM medium without phenol red and supplemented with 3% of
charcoal-stripped fetal bovine serum and antibiotics. Afterward,
cells were treated with water-soluble estradiol (100 ng/ml) and
progesterone (10 pg/ml) (both from Sigma-Aldrich, Taufkirchen,
Germany) for 24 h. These concentrations were chosen as they
represent the physiological values found in healthy women at
ovulation.
PROTEIN ISOLATION
Protein isolation and quantification were done following a stan-
dard protocol established in our laboratory (17). AN3 cells were re-
suspended and homogenized in lysis buffer (1% NP-40, 0.1 mg/ml
n-dodecyl beta maltoside, 10 mM NAO3V, 1 M Tris pH 7.5, 5 m
NaCl, 500 mM NaF, 500 mM EDTA pH 7.5, 100 mM PMSF) for
45 min. Homogenates were centrifuged at 12,000 rpm for 20 min
at 4°C and the supernatant containing the proteins was collected.
Protein was isolated from tissue samples (uterus) from the phenol
phase from the Trizol RNA isolation. Protein concentration was
assessed by using the Pierce BCA protein assay (Thermo Fisher Sci-
entific, Bonn, Germany) as indicated by the manufacturer. Protein
samples were kept at−80°C until use.
WESTERN BLOT
For western blot analysis, 20µg of proteins was transferred into a
12% polyacrylamide gel and a SDS-PAGE in denaturizing condi-
tions was performed at 100 V. After the electrophoresis, proteins
were transferred into PVDF membranes in transfer buffer contain-
ing 20% methanol (v/v), 0.19 M glycine, and 0.025 M Tris-base
of pH 8.3. For protein detection, membranes were incubated
overnight (ON) with a specific rabbit anti-human HO-1 anti-
body (Enzo Life Science, Lörrach, Germany). After three washing
steps with TBST (TBS with 0.5% Tween) for 5 min each, the
membranes were incubated with an anti-rabbit HRP-conjugated
(Thermo Fisher Scientific, Schwerte, Germany) antibody diluted
1:2000 for 1 h at RT and then with avidin–horseradish peroxidase
complex (ABC complex, Biozol, Eching, Germany). GAPDH was
used as loading control in the same gel and applied together with
the HO-1 antibody. The chemiluminescence signal was generated
by using luminol (A8511-5G, Sigma-Aldrich), 4-hydroxycinnamic
acid (p-coumaric acid; C9008-25G, Sigma-Aldrich), and hydro-
gen peroxide (Merck, Darmstadt, Germany). The intensity of the
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bands was quantified by using the GeneSnap® Software, Version
4.01c from Syngene, Darmstadt, Germany.
STATISTICS
All data presented in this manuscript are normally distributed
and shown as mean± SD. The number of animals included in
each experiment is specified in the figures. Differences among
two groups were analyzed by paired t -test using two-way ANOVA
and applied to compare three or more groups. All analyses
were performed using Graph Pad (#p< 0.1 and *p< 0.05). The
non-parametric Spearman correlation was used to analyze the
correlation of RT-PCR and ELISA data.
RESULTS
SERUM PROGESTERONE LEVELS PEAK DURING ESTRUS OF THE
ESTROUS CYCLE
We first determined the phase of the estrous cycle in virgin mice by
analyzing the cellular content of their vaginal lavage after staining
with hematoxylin/eosin. At proestrus, mostly nucleated and few
cornified cells are present along with some leukocytes. In estrus,
only cornified cells are present. At metestrus, cornified epithe-
lial cells and leukocytes are present while at diestrus, which is
the longest phase, only leukocytes are seen accompanied by few
epithelial nucleated cells (Figure 1).
To quantify hormone levels (progesterone and estradiol), we
employed ELISA assays with n= 5 animals/phase. We observed, as
expected, a peak in progesterone levels during estrus, associated
with a decrease in estradiol (Figures 2A,B, respectively).
HO-1 UTERINE EXPRESSION PEAKS DURING RECEPTIVE PERIOD
We next asked whether HO-1 expression in the uterus of wild
type (Hmox1+/+) mice of BALB/c background would be regulated
FIGURE 1 | Representative pictures from hematoxylin/eosin-stained
samples from vaginal lavage at each phase of the estrous cycle in
Hmox1+/+ BALB/c female mice. At diestrus, only leukocytes can be
observed, accompanied by few epithelial nucleated cells. At proestrus,
mostly nucleated and few cornified cells are present along with some
leukocytes. In estrus (at receptivity), only cornified cells are present. At
metestrus, cornified epithelial cells and leukocytes are present.
by hormonal changes during the estrous cycle. That would indi-
cate that HO-1 is implied in female sexual receptivity that occurs
during the estrus period of the estrous cycle in which ovulation
takes place (18). There was a slight but significant increase in the
level of Hmox1 mRNA expression in the transition from diestrus
to proestrus phase of the estrous cycle (Figure 3A), followed by
stronger increase thereafter, reaching maximal levels at the estrus
phase (Figure 3A), thus coinciding with the phase of the estrous
cycle associated with maximal receptivity (18). Interestingly, the
mRNA HO-1 peak was associated with the progesterone peak and
there was a statistically significant positive correlation among these
two (Figure 3B). At protein level, HO-1 was augmented in estrus
compared to proestrus and metestrus (Figure S1 in Supplementary
Material). Accordingly, the levels of free heme, the HO-1 substrate,
in uterine lavage were diminished at this time point, albeit not
statistically significant (Figure 3C) while they were unaltered in
FIGURE 2 |The concentration of progesterone (A) and estradiol (B)
during the estrous cycle (n=16, 4/cycle). Progesterone and estradiol
levels in plasma were analyzed by ELISA following the instructions of the
manufacturer. n=4 mice/phase were included and the statistic analysis
was performed by two-way ANOVA. #p<0.1.
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FIGURE 3 | HO-1 and heme levels at different phases of the estrous
cycle. (A) HO-1 mRNA levels in uterine tissue of Hmox1+/+ female mice
(n= 4/phase) and (B) the positive correlation between HO-1 mRNA levels
in the uterus and progesterone concentrations in serum. (C)The levels of
heme in uterine lavage and (D) heme levels in plasma. (E) HO-1 mRNA
levels in spleen of Hmox1+/+ female mice. *p<0.05, n=4 mice/phase
were included and the statistic analysis was performed by two-way
ANOVA.
spleen (Figure 3D). Levels of Hmox1 mRNA expression normal-
ized to beta-actin in spleen showed no significant changes during
the cycle (Figure 3E). Our data suggest that the interaction HO-
1/hormones is unidirectional, as hormones clearly influence HO-1
expression as shown here but HO-1 or its absence does not seem
to influence hormone levels (7).
APPLICATION OF PHYSIOLOGICAL CONCENTRATIONS OF
PROGESTERONE PLUS ESTRADIOL PROVOKED AN UP-REGULATION OF
HO-1 PROTEIN LEVELS IN AN3 CELLS
To certainly confirm the modulation of uterine HO-1 by hor-
mones, we next studied their effect on HO-1 protein expression
in uterine cells, namely AN3 (15). We observed that the addition
of combined progesterone and estradiol provoked a significant
augmentation in the HO-1 expression after 24 h (Figure 4). This
was not a result of cellular stress due to the culture as HO-1 did
not augment in cells cultured without hormones (Figure 4). Thus,
HO-1 expression in uterine cells depends on female hormones.
DISCUSSION
Heme oxygenase is a ubiquitous enzyme that catalyzes the initial
and rate-limiting steps in the oxidative degradation of heme to
bilirubin (1). HO cleaves a mesocarbon of the heme molecule,
producing equimolar quantities of biliverdin, iron, and carbon
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FIGURE 4 |The representative results of three in vitro experiments in
which AN3 cells were cultured in the presence or absence of estrogen
(E2) and progesterone (P4) for 24h. (A)The levels of HO-1 relative to
GAPDH were elevated in the cells treated with hormones compared to the
controls. (B) Representative western blots. The data are expressed as
mean±SEM. *p<0.05; n=4, the statistic analysis was performed by
two-way ANOVA.
monoxide (CO). CO and biliverdin, both generated via the catabo-
lism of heme by the isoform HO-1, are potent immunosuppressors
[revised in Ref. (2, 12)]. HO-1 emerges as a critical regulator of
pregnancy success as it determines intrauterine fetal survival. HO-
1 positively influences placentation and fetal growth by avoiding
the toxic effects of free heme (7). It seems that the presence of
HO-1 avoids the accumulation of free heme that is toxic for the
tissues (7). As at the fetal–maternal interface the amount of circu-
lating blood is enormous, it is clear that the inadequate clearance
of hemoglobin-derived free heme has pathologic consequences.
Not only is HO-1 protective because of main activity, which is
to catabolize free heme, but also it has been shown that HO-1
positively influences the adaptive immune system and provokes a
bias toward a protective response that was highlighted in several
inflammation models (12). In fact, we found that later in preg-
nancy, when immunological tolerance is needed, HO-1 modulates
the maternal immune system to allow tolerance toward the grow-
ing fetus (9, 10). Hence, HO-1 acts at different levels and different
time points of pregnancy to support implantation, placentation,
fetal growth, and immune tolerance.
It is known that hormones in general and progesterone in
particular prepare the uterus for nidation (19). Estrogen and prog-
esterone are necessary for implantation of the blastocyst, and the
preimplantation estrogen surge is essential for implantation in
mice. As HO-1 is a molecule that avoids tissue damage because
of excessive inflammation and implantation is an inflammatory
process, it is possible that HO-1 is implied at this stage. As the sub-
fertility of Hmox1± and Hmox1−/− mice can have multiple causes
despite the ones we already found (7, 8), we asked here whether
the HO-1 expression in the uterus of wild type (Hmox1+/+) mice
may be regulated by hormones controlling female sexual receptiv-
ity. HO-1 mRNA expression reached its maximal level at the estrus
phase, thus coinciding with maximal receptivity (18). Accordingly,
the levels of heme, the HO-1 substrate, in uterine lavage were
reduced at this time point, confirming increased HO-1 activity.
Interestingly, HO-1 peak in the uterus coincided with the aug-
mentation of progesterone in serum during estrus phase, this
positive correlation being statistically significant. Thus, it is tempt-
ing to speculate that the expression of uterine HO-1 is regulated
by hormonal changes during the estrous cycle. HO-1 expression
might influence sexual receptivity in the uterus thus regulating
the frequency of pregnancies when mating, e.g., Hmox1± mice to
maintain the colony. Uterine receptivity implies the highest prog-
esterone and the highest HO-1 in the uterine tissue; this would
protect it from excessive inflammation at nidation of the egg and
posterior implantation. Here, we found that expression of HO-
1 peaks during the receptive period. This was inverse to what
we observed for the heme concentration, which indicates that
heme/HO-1 dictate the receptivity in the uterus and would in
part explain the lower frequencies of pregnancies in a period of
1 year in mice partially deficient in HO-1 (unpublished observa-
tions). The direct effect of hormones, progesterone and estrogen,
on the expression of uterine HO-1 was confirmed in vitro in
uterine AN3 cells. This strengthens the hypothesis of hormones
dictating the concentration of HO-1, a cytoprotective molecule,
in uterine tissue.
Cella and colleagues described that the application of estrogens
and progesterones to ovariectomized rats provoked an increase
in HO-1 expression (20). The authors interpreted these results as
HO-1 being important for defense against oxidative stress. Prog-
esterone modulation of uterine HO-1 by hormones may also be
relevant to maintain uterine quiescence as HO-1 induction limited
uterine contractility in pregnant myometrium (21).
From our published work, we know that HO-1 expression in
oocytes promotes ovulation, probably by affording cytoprotection
during the process of follicular rupture, a proinflammatory event
associated with tissue injury, including hemolysis (8). HO-1 fur-
ther influences positively trophoblast survival and differentiation
from stem cells into giant cells, it influences the attachment of
the blastocyst to the uterine epithelial wall and thus the qual-
ity of implantation. As a consequence, we found HO-1 to be
important for placentation and fetal growth (7). HO-1 later mod-
ulates cells of the innate and adaptive immune system to have a
pregnancy-supporting tolerant immune response. Here, we show
that additionally to all these pregnancy-fostering actions, hor-
mones modulate HO-1 expression so it can be highly expressed
at receptivity in the uterus. Our data add one more piece to the
fascinating puzzle that is pregnancy establishment and support.
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Figure S1 |Western Blots for HO-1 and GAPDH performed with uterus
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the estrous cycle (n=4/each). At the bottom, the ratio of HO-1/GAPDH is
expressed as mean±SEM.
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